Skip to the page

Data / Form D filings / Animal Biosciences, Inc.

Animal Biosciences, Inc.: Form D filings

Animal Biosciences, Inc., a company in Boston, MA, filed 3 Form D notices with the SEC between 2020 and 2026. The latest, on September 9, 2026, reports $2.3 million sold of a $2.6 million offering to 15 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
361 Newbury St Fl 5, Boston, MA, 02115
Phone
(617) 651-6175
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1826176

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 9, 2026New notice$2,610,000$2,320,000$290,00015Aug 17, 2026sec.gov
Jan 7, 2022New notice$4,000,000$1,699,997$2,300,0033Dec 23, 2021sec.gov
Sep 25, 2020New notice$2,000,000$633,531$1,366,4692Sep 11, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Virginia RentkoExecutive Officer, Director
Nicholas SinclairDirector
Petr SramekDirector
Jared BarlowDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of Sep 7, 2026 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what Animal Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.